Recent Updates
Recently added Catalysts
HCA Positive Sentiment

HCA Healthcare Reports Third Quarter 2026 Results

Tuesday, October 27, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: HCA Healthcare reported its third quarter results for 2026, showing a revenue increase of 3.6% to $19.849 billion. However, net income fell by 3.9% to $1.579 billion. Despite this, diluted earnings per share rose by 4.5% to $7.27, indicating some positive financial performance.

Market Sentiment Analysis

POSITIVE FACTORS

  • Revenues increased by 3.6 percent to $19.849 billion.
  • Diluted earnings per share rose by 4.5 percent to $7.27.

CONCERNS & RISKS

  • Net income attributable to HCA declined by 3.9 percent.

Full Press Release Details

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2026. Key third quarter metrics (all percentage changes compare 3Q 2026 to 3Q 2025 unless otherwise noted): Revenues increased 3.6 percent to $19.849 billion Net income attributable to HCA Healthcare, Inc. declined 3.9 percent to $1.579 billion Diluted earnings per share increased 4.5 percent to $7.27 per diluted share, and diluted earning

Frequently Asked Questions

What were HCA's revenues for Q3 2026?

HCA's revenues for Q3 2026 were $19.849 billion.

How much did HCA's net income decline?

HCA's net income declined by 3.9% to $1.579 billion.

What was the diluted earnings per share for HCA?

The diluted earnings per share for HCA was $7.27.

What percentage increase did HCA see in diluted earnings?

HCA saw a 4.5% increase in diluted earnings per share.

ShareAdd on Google
Tags: HCA HCA Healthcare Q3 2026 financial results earnings report revenue growth
Last updated: Oct 27, 2026

Biotech snapshot

Cash runway
$1013M liquidity · $0M/mo burn
Low dilution risk